New Painless Test For Cervical Cancer Could Provide Access To Better Healthcare For Women Worldwide

A new non-invasive test that scans for cervical cancer, being developed by SpectRx, Inc. (Pink Sheets: SPRX), may lead to earlier detection of cervical disease in women of developing countries that lack the infrastructure to perform Pap or human papilloma virus (HPV) testing. According to the World Health Organization, cervical cancer is the second most common cancer in women and the most common in developing countries. [click link for full article]

More: continued here

Filed under: Cervical Cancer on November 3rd, 2007